TrialGut2017
The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS.
J Tack et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it